BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30663155)

  • 1. Successful treatment of microcystic adnexal carcinoma on the philtrum with oral S-1 monotherapy.
    Haga T; Fujimura T; Aiba S
    J Dermatol; 2019 Jun; 46(6):e208-e209. PubMed ID: 30663155
    [No Abstract]   [Full Text] [Related]  

  • 2. The first reported case of metastatic microcystic adnexal carcinoma in an adolescent.
    Chaudhari S; Blanchard L; Chaudhari PJ; Lythgoe T
    Dermatol Surg; 2015 Feb; 41(2):286-8. PubMed ID: 25627630
    [No Abstract]   [Full Text] [Related]  

  • 3. Squamoid Eccrine Ductal Carcinoma: The Scripps Experience.
    Chow P; Goddard L; Greenway HT; Kelley BF
    Dermatol Surg; 2021 Aug; 47(8):1115-1117. PubMed ID: 34115678
    [No Abstract]   [Full Text] [Related]  

  • 4. Sweat gland carcinoma with lung metastases.
    Bahl A; Sharma DN; Julka PK; Das A; Rath GK
    J Cancer Res Ther; 2006; 2(4):209-11. PubMed ID: 17998708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of advanced cutaneous squamous cell carcinoma of the lower eyelid that was successfully treated with tegafur-gimeracil-oteracil potassium monotherapy.
    Yamamoto Y; Nakai N; Wakabayashi Y; Okuzawa Y; Asai J; Takenaka H; Katoh N
    J Am Acad Dermatol; 2012 Nov; 67(5):e233-4. PubMed ID: 23062933
    [No Abstract]   [Full Text] [Related]  

  • 6. A multicenter phase II study of adjuvant chemotherapy with oral fluoropyrimidine S-1 for non-small-cell lung cancer: high completion and survival rates.
    Tsuchiya T; Nagayasu T; Yamasaki N; Matsumoto K; Miyazaki T; Tagawa T; Nakamura A; Minami H; Taniguchi H; Akamine S; Hisano H; Taniguchi Y
    Clin Lung Cancer; 2012 Nov; 13(6):464-9. PubMed ID: 22424872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tegafur/gimeracil/oteracil (Teysuno), by oral administration].
    Duh D; Warnez M
    J Pharm Belg; 2013 Dec; (4):35-6. PubMed ID: 24449972
    [No Abstract]   [Full Text] [Related]  

  • 8. Supraorbital neuroma masquerading as local recurrence from a previously excised microcystic adnexal carcinoma.
    Seaward JR; Kalipershad SN; Ross GL
    J Plast Reconstr Aesthet Surg; 2010 Mar; 63(3):e239-41. PubMed ID: 19648071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcystic adnexal (sclerosing sweat duct) carcinoma of intraoral minor salivary gland origin: an extracutaneous adnexal neoplasm?
    Ide F; Kikuchi K; Kusama K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):284-6. PubMed ID: 21684772
    [No Abstract]   [Full Text] [Related]  

  • 10. How long should we continue S-1 as adjuvant chemotherapy for squamous cell carcinoma of the head and neck?
    Hirai M; Orita Y; Takao S; Tachibana T; Marunaka H; Makihara S; Miki K; Noyama Y; Fuji S; Torigoe A; Sato Y; Nishizaki K
    Acta Otolaryngol; 2015; 135(10):1079-85. PubMed ID: 26004393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer.
    Suzuki S; Ishikawa K
    J Infect Chemother; 2009 Oct; 15(5):335-9. PubMed ID: 19856075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
    Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
    PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant S-1 chemotherapy after curative resection of gastric cancer in Chinese patients: assessment of treatment tolerability and associated risk factors.
    Yeo W; Lam KO; Law AL; Lee CC; Chiang CL; Au KH; Mo FK; So TH; Lam KC; Ng WT; Li L
    Hong Kong Med J; 2017 Feb; 23(1):54-62. PubMed ID: 27966431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial.
    Ito S; Ohashi Y; Sasako M
    BMC Cancer; 2018 Apr; 18(1):449. PubMed ID: 29678146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Just when you thought the fluorouracil debate was over: S-1 and gastric cancer.
    Ilson D
    J Clin Oncol; 2005 Oct; 23(28):6826-8. PubMed ID: 16145059
    [No Abstract]   [Full Text] [Related]  

  • 16. [Development of oral drugs in the standard therapy for metastatic colorectal cancer patients].
    Kato K
    Nihon Rinsho; 2011 Apr; 69 Suppl 3():454-8. PubMed ID: 22214003
    [No Abstract]   [Full Text] [Related]  

  • 17. Microcystic adnexal carcinoma of the skin: the role of adjuvant radiotherapy.
    Baxi S; Deb S; Weedon D; Baumann K; Poulsen M
    J Med Imaging Radiat Oncol; 2010 Oct; 54(5):477-82. PubMed ID: 20958947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant chemotherapy with S-1 for advanced head and neck carcinoma].
    Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Taguchi T; Yoshida T; Toth G
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():172-8. PubMed ID: 16897997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of advanced gastric cancer with paraaortic lymph node recurrence reaching a long-term survival by S-1 chemotherapy].
    Matsumura H; Iwasaki Y; Ohashi M; Iwanaga T; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2284-6. PubMed ID: 20037397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alternate-day oral therapy with S-1 for adjuvant chemotherapy of gastric cancer].
    Takebayashi K; Kawai Y; Tagi T; Matsumura M; Shimizu K; Yamamoto H; Mekata E; Tani T; Sato M
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):385-7. PubMed ID: 22421764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.